837 related articles for article (PubMed ID: 28655834)
1. Risk for Major Bleeding in Patients Receiving Ticagrelor Compared With Aspirin After Transient Ischemic Attack or Acute Ischemic Stroke in the SOCRATES Study (Acute Stroke or Transient Ischemic Attack Treated With Aspirin or Ticagrelor and Patient Outcomes).
Easton JD; Aunes M; Albers GW; Amarenco P; Bokelund-Singh S; Denison H; Evans SR; Held P; Jahreskog M; Jonasson J; Minematsu K; Molina CA; Wang Y; Wong KSL; Johnston SC;
Circulation; 2017 Sep; 136(10):907-916. PubMed ID: 28655834
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and Safety of Ticagrelor in Relation to Aspirin Use Within the Week Before Randomization in the SOCRATES Trial.
Wong KSL; Amarenco P; Albers GW; Denison H; Easton JD; Evans SR; Held P; Himmelmann A; Kasner SE; Knutsson M; Ladenvall P; Minematsu K; Molina CA; Wang Y; Johnston SC;
Stroke; 2018 Jul; 49(7):1678-1685. PubMed ID: 29915123
[TBL] [Abstract][Full Text] [Related]
3. Ticagrelor in Acute Stroke or Transient Ischemic Attack in Asian Patients: From the SOCRATES Trial (Acute Stroke or Transient Ischemic Attack Treated With Aspirin or Ticagrelor and Patient Outcomes).
Wang Y; Minematsu K; Wong KS; Amarenco P; Albers GW; Denison H; Easton JD; Evans SR; Held P; Jonasson J; Molina CA; Johnston SC;
Stroke; 2017 Jan; 48(1):167-173. PubMed ID: 27899747
[TBL] [Abstract][Full Text] [Related]
4. Ticagrelor versus Aspirin in Acute Stroke or Transient Ischemic Attack.
Johnston SC; Amarenco P; Albers GW; Denison H; Easton JD; Evans SR; Held P; Jonasson J; Minematsu K; Molina CA; Wang Y; Wong KS;
N Engl J Med; 2016 Jul; 375(1):35-43. PubMed ID: 27160892
[TBL] [Abstract][Full Text] [Related]
5. Prevention of Stroke with Ticagrelor in Patients with Prior Myocardial Infarction: Insights from PEGASUS-TIMI 54 (Prevention of Cardiovascular Events in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin-Thrombolysis in Myocardial Infarction 54).
Bonaca MP; Goto S; Bhatt DL; Steg PG; Storey RF; Cohen M; Goodrich E; Mauri L; Ophuis TO; Ruda M; Špinar J; Seung KB; Hu D; Dalby AJ; Jensen E; Held P; Morrow DA; Braunwald E; Sabatine MS
Circulation; 2016 Sep; 134(12):861-71. PubMed ID: 27576775
[TBL] [Abstract][Full Text] [Related]
6. Reduction in first and recurrent cardiovascular events with ticagrelor compared with clopidogrel in the PLATO Study.
Kohli P; Wallentin L; Reyes E; Horrow J; Husted S; Angiolillo DJ; Ardissino D; Maurer G; Morais J; Nicolau JC; Oto A; Storey RF; James SK; Cannon CP
Circulation; 2013 Feb; 127(6):673-80. PubMed ID: 23277305
[TBL] [Abstract][Full Text] [Related]
7. Acute Stroke or Transient Ischemic Attack Treated with Aspirin or Ticagrelor and Patient Outcomes (SOCRATES) trial: rationale and design.
Johnston SC; Amarenco P; Albers GW; Denison H; Easton JD; Held P; Jonasson J; Minematsu K; Molina CA; Wong LK
Int J Stroke; 2015 Dec; 10(8):1304-8. PubMed ID: 26311628
[TBL] [Abstract][Full Text] [Related]
8. Ticagrelor versus clopidogrel in patients with acute coronary syndromes and a history of stroke or transient ischemic attack.
James SK; Storey RF; Khurmi NS; Husted S; Keltai M; Mahaffey KW; Maya J; Morais J; Lopes RD; Nicolau JC; Pais P; Raev D; Lopez-Sendon JL; Stevens SR; Becker RC;
Circulation; 2012 Jun; 125(23):2914-21. PubMed ID: 22572911
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of ticagrelor versus aspirin in acute stroke or transient ischaemic attack of atherosclerotic origin: a subgroup analysis of SOCRATES, a randomised, double-blind, controlled trial.
Amarenco P; Albers GW; Denison H; Easton JD; Evans SR; Held P; Hill MD; Jonasson J; Kasner SE; Ladenvall P; Minematsu K; Molina CA; Wang Y; Wong KSL; Johnston SC;
Lancet Neurol; 2017 Apr; 16(4):301-310. PubMed ID: 28238711
[TBL] [Abstract][Full Text] [Related]
10. Time to Loading Dose and Risk of Recurrent Events in the SOCRATES Trial.
Molina CA; Johnston SC; Ladenvall P; Amarenco P; Albers GW; Denison H; Easton JD; Evans SR; Held P; Knutsson M; Minematsu K; Röther J; Wang Y; Wong KSL;
Stroke; 2019 Mar; 50(3):675-682. PubMed ID: 30776996
[TBL] [Abstract][Full Text] [Related]
11. Ticagrelor for Prevention of Ischemic Events After Myocardial Infarction in Patients With Peripheral Artery Disease.
Bonaca MP; Bhatt DL; Storey RF; Steg PG; Cohen M; Kuder J; Goodrich E; Nicolau JC; Parkhomenko A; López-Sendón J; Dellborg M; Dalby A; Špinar J; Aylward P; Corbalán R; Abola MTB; Jensen EC; Held P; Braunwald E; Sabatine MS
J Am Coll Cardiol; 2016 Jun; 67(23):2719-2728. PubMed ID: 27046162
[TBL] [Abstract][Full Text] [Related]
12. The Acute S
Johnston SC; Amarenco P; Denison H; Evans SR; Himmelmann A; James S; Knutsson M; Ladenvall P; Molina CA; Wang Y;
Int J Stroke; 2019 Oct; 14(7):745-751. PubMed ID: 30747613
[TBL] [Abstract][Full Text] [Related]
13. Estimated treatment effect of ticagrelor versus aspirin by investigator-assessed events compared with judgement by an independent event adjudication committee in the SOCRATES trial.
Easton JD; Denison H; Evans SR; Knutsson M; Amarenco P; Albers GW; Ladenvall P; Minematsu K; Molina CA; Wang Y; Wong KL; Johnston SC;
Int J Stroke; 2019 Dec; 14(9):908-914. PubMed ID: 31092152
[TBL] [Abstract][Full Text] [Related]
14. Ticagrelor and Aspirin or Aspirin Alone in Acute Ischemic Stroke or TIA.
Johnston SC; Amarenco P; Denison H; Evans SR; Himmelmann A; James S; Knutsson M; Ladenvall P; Molina CA; Wang Y;
N Engl J Med; 2020 Jul; 383(3):207-217. PubMed ID: 32668111
[TBL] [Abstract][Full Text] [Related]
15. Ischemic Benefit and Hemorrhage Risk of Ticagrelor-Aspirin Versus Aspirin in Patients With Acute Ischemic Stroke or Transient Ischemic Attack.
Johnston SC; Amarenco P; Aunes M; Denison H; Evans SR; Himmelmann A; Jahreskog M; James S; Knutsson M; Ladenvall P; Molina CA; Nylander S; Röther J; Wang Y;
Stroke; 2021 Nov; 52(11):3482-3489. PubMed ID: 34477459
[TBL] [Abstract][Full Text] [Related]
16. P2Y12 Inhibitors Plus Aspirin Versus Aspirin Alone in Patients With Minor Stroke or High-Risk Transient Ischemic Attack.
Li ZX; Xiong Y; Gu HQ; Fisher M; Xian Y; Johnston SC; Wang YJ
Stroke; 2021 Jul; 52(7):2250-2257. PubMed ID: 34039032
[TBL] [Abstract][Full Text] [Related]
17. Reduction in Ischemic Events With Ticagrelor in Diabetic Patients With Prior Myocardial Infarction in PEGASUS-TIMI 54.
Bhatt DL; Bonaca MP; Bansilal S; Angiolillo DJ; Cohen M; Storey RF; Im K; Murphy SA; Held P; Braunwald E; Sabatine MS; Steg PG
J Am Coll Cardiol; 2016 Jun; 67(23):2732-2740. PubMed ID: 27046160
[TBL] [Abstract][Full Text] [Related]
18. Long-term antiplatelet therapy following myocardial infarction: implications of PEGASUS-TIMI 54.
Parker WA; Storey RF
Heart; 2016 May; 102(10):783-9. PubMed ID: 26857211
[TBL] [Abstract][Full Text] [Related]
19. [The association of lipid profile and bleeding in patients with minor stroke or transient ischemic attack on antiplatelet therapy: subgroup analysis of CHANCE].
Li JJ; Gu HQ; Peng YJ; Zhao XQ; Wang YL; Meng X; Liu LP; Wang YJ
Zhonghua Nei Ke Za Zhi; 2018 Oct; 57(10):723-730. PubMed ID: 30293332
[No Abstract] [Full Text] [Related]
20. Ticagrelor Versus Clopidogrel in Minor Stroke or Transient Ischemic Attack With Intracranial Artery Stenosis: A Post Hoc Analysis of CHANCE-2.
Wang C; Jia W; Jing J; Meng X; Wang A; Xu Q; Zhang X; Pan Y; Xie X; Johnston SC; Bath PM; Lin J; Jiang Y; Li H; Wang Y; Zhao X; Liu L; Li Z; Wang Y;
J Am Heart Assoc; 2023 Nov; 12(21):e031611. PubMed ID: 37889172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
